Stock & Company Details
Damora Therapeutics $DMRA
Price:
N/A
N/A
62M
$1.3B
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.16
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
N/A
DMRA technical indicators
Latest Damora Therapeutics (DMRA) indicator readings as of 2026-10-29.
DMRA's 14-day RSI is 53.1, in neutral territory. Price sits near the upper Bollinger Band ($18.06 to $22.73). ADX reads 20.8, sitting between trending and range-bound.
Overview
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
Finance Bot
Ask your questions
Start by typing a question below.
